BCX4430
BCX4430-101
Phase 1 small_molecule completed
Quick answer
BCX4430 for Filovirus Infections is a Phase 1 program (small_molecule) at BIOCRYST PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BIOCRYST PHARMACEUTICALS INC
- Indication
- Filovirus Infections
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed